Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Price:
525.68
USD
-1.77%
Market Closed
Market Cap:
$133.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
|
P
|
Pinetree Capital Ltd
F:PI1
|
CA |
|
F
|
First Hydrogen Corp
XTSX:FHYD
|
CA |
|
Phillips 66
NYSE:PSX
|
US |
|
I
|
Ithaca Energy PLC
LSE:ITH
|
UK |
|
P
|
Playwith Inc
KOSDAQ:023770
|
KR |
|
TGS ASA
F:TGC0
|
NO |
|
P
|
Pierre et Vacances SA
F:PV6
|
FR |
|
Femasys Inc
NASDAQ:FEMY
|
US |
|
TGS ASA
F:TGC
|
NO |
Wall St Price Targets
VRTX Price Forecast
Based on 31 analysts
Based on 31 analysts
+13% Upside
from
$525.68
today
Vertex Pharmaceuticals Inc (VRTX)’s 12-month stock price forecast through October 2027 has a consensus target of $591.6, implying 13% upside. The forecast is based on price targets from 31 Wall Street analysts.
VRTX Analyst Rating
Based on 32 analysts
Based on 32 analysts
Analysts rate VRTX Buy, with 26 of 32 recommending Buy or Strong buy.
Vertex Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRTX's stock price target?
Price Target
591.6
USD
591.6
USD
According to Wall Street analysts, the average 1-year price target for VRTX is 591.6 USD with a low forecast of 353.5 USD and a high forecast of 700.35 USD.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
11%
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
17%
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 8 years is 17%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
20%
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
16%
16%
The compound annual growth rate for Net Income over the next 8 years is 16%.